Genomics

Dataset Information

Synthetic RIG-I agonist-mediated cancer immunotherapy synergizes with MAP-Kinase inhibition against BRAF mutated melanoma


ABSTRACT: Synthetic RIG-I agonist-mediated cancer immunotherapy synergizes with MAP-Kinase inhibition against BRAF mutated melanoma

PROVIDER: PRJNA1119558 | ENA |

REPOSITORIES: ENA